Last Updated on May 02, 2022


Press Releases

Official News and Updates from the Preeclampsia Foundation

MoMMA’s Voices Program Receives CDC Award to Connect Patients to Maternal Health Quality Improvement Projects
October 03, 2023
MoMMA’s Voices Program Receives CDC Award to Connect Patients to Maternal Health Quality Improvement Projects

The Preeclampsia Foundation announced today that the Centers for Disease Control and Prevention (CDC) awarded new funding for its MoMMA’s Voices program, a national coalition of patient advocacy organizations and individuals with "lived experience" –...

Abt, HealthBegins, Preeclampsia Foundation Receive HRSA Contract to Advance Equitable Maternal Health Outcomes
September 07, 2023
Abt, HealthBegins, Preeclampsia Foundation Receive HRSA Contract to Advance Equitable Maternal Health Outcomes

Abt Associates, together with subcontractors HealthBegins and the MoMMA’s Voices program of the Preeclampsia Foundation, will provide technical assistance and evaluation support to 36 HRSA-supported health centers who are implementing innovative appr...

2023 Preeclampsia Foundation Vision Grant Awardees Announced
August 28, 2023
2023 Preeclampsia Foundation Vision Grant Awardees Announced

Preeclampsia Foundation Canada has announced that Kylie Belchamber, PhD of University of Birmingham, and Serena Gundy, MD, FRCP of McMaster University, are their 2023 Vision Grant research award recipients. These highly competitive monetary awards re...

Preeclampsia Foundation-funded genetic research study finds two distinct molecular “faces”  of preeclampsia
August 28, 2023
Preeclampsia Foundation-funded genetic research study finds two distinct molecular “faces” of preeclampsia

New preeclampsia research funded by Preeclampsia Foundation Peter J. Pappas grant finds distinct genetic traits of early-onset preeclampsia.

Promise Walk Wherever uses individual action to fuel research, raise awareness of preeclampsia
August 22, 2023
Promise Walk Wherever uses individual action to fuel research, raise awareness of preeclampsia

Preeclampsia survivors and their supporters will hit the pavement with a purpose on Saturday, August 26, as part of the fourth annual Promise Walk Wherever event sponsored by the Preeclampsia Foundation.

New Scientific Research Funding Available to Eliminate Pre-Term Deliveries from Preeclampsia
July 03, 2023
New Scientific Research Funding Available to Eliminate Pre-Term Deliveries from Preeclampsia

The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia research for two, two-year grants of up to $200,000.

Thermo Fisher Scientific Gets FDA Clearance for Preeclampsia Risk Assessment Assays
May 19, 2023
Thermo Fisher Scientific Gets FDA Clearance for Preeclampsia Risk Assessment Assays

A new diagnostic test for preeclampsia has received approval from the US Food and Drug Administration for use in hospital settings.

First Comprehensive Care Plan to Prevent Preeclampsia Published in the American Journal of Obstetrics and Gynecology
April 28, 2023
First Comprehensive Care Plan to Prevent Preeclampsia Published in the American Journal of Obstetrics and Gynecology

Recommendations for high-risk expecting parents and health care providers to promote the prevention of preeclampsia, a leading cause of pregnancy-related death in the United States.

Preeclampsia Foundation Canada announces 2023 Vision Grant Research Funding for Preeclampsia at 2023 SMFM Pregnancy Meeting
February 08, 2023
Preeclampsia Foundation Canada announces 2023 Vision Grant Research Funding for Preeclampsia at 2023 SMFM Pregnancy Meeting

Preeclampsia Foundation Canada announced today at the Society for Maternal-Fetal Medicine’s (SMFM) 43rd Annual Meeting – The Pregnancy Meeting™ – that applications are now being accepted for its 2023 Vision Grant program.

New Preeclampsia Research Funded to Investigate Genetic Targets to Develop Potential Therapeutics
February 08, 2023
New Preeclampsia Research Funded to Investigate Genetic Targets to Develop Potential Therapeutics

The study is designed to potentially accelerate discovery of therapies for preeclampsia by designing placental cell lines that express variants of the APOL1 gene for drug screening.

Promise Walk Wherever uses individual action to fuel research, raise awareness of preeclampsia
August 24, 2022
Promise Walk Wherever uses individual action to fuel research, raise awareness of preeclampsia

Preeclampsia survivors and their supporters will hit the pavement with a purpose on Saturday, August 27, as part of the third annual Promise Walk Wherever event sponsored by the Preeclampsia Foundation.

LOAD MORE

Related Articles